ETHAMCIP 250

Description

ETHAMCIP 250 Tablet contains Ethamsylate B.P. 250mg as its active ingredient, manufactured by Cipla Ltd. Ethamsylate is a synthetic hemostatic agent prescribed primarily for the prevention and reduction of abnormal bleeding. It acts by increasing the ability of platelets to stick together and helping form blood clots, thereby stabilizing capillary walls and reducing blood loss from tiny vessels.

This tablet is typically used in conditions such as heavy or abnormal menstrual bleeding, dysfunctional uterine bleeding, and to prevent or control bleeding during, before, or after delicate surgical procedures. ETHAMCIP 250 may also be indicated in other situations where there is increased risk of blood loss, including some bleeding disorders.

The medication should be taken exactly as directed by your doctor, with dosage and duration depending on the specific condition being treated. It can be taken with or without food, preferably at the same time each day to maintain consistent blood levels.

Common side effects include nausea, headache, skin rash, vomiting, and diarrhea, which are generally mild and temporary. Inform your physician if you have any history of liver, heart, or kidney disease, or if you experience any persistent or severe reactions. ETHAMCIP 250 should not be used in patients with allergy to ethamsylate or certain blood disorders unless specifically prescribed.

If you miss a dose, take it as soon as you remember; do not double up doses. Before starting this medication, disclose all your existing medical conditions and medicines to your doctor for safe administration. Use in pregnancy or breastfeeding should be discussed with your healthcare provider.

ETHAMCIP 250 Tablet is an effective option to reduce blood loss and prevent complications associated with excessive bleeding when taken under medical supervision.